Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-related emergent zoonotic coronaviruses is urgently needed. We made homotypic nanoparticles displaying the receptor binding domain (RBD) of SARS-CoV-2 or co-displaying SARS-CoV-2 RBD along with RBDs from animal betacoronaviruses that represent threats to humans (mosaic nanoparticles with four to eight distinct RBDs). Mice immunized with RBD nanoparticles, but not soluble antigen, elicited cross-reactive binding and neutralization responses. Mosaic RBD nanoparticles elicited antibodies with superior cross-reactive recognition of heterologous RBDs relative to sera from immunizations with homotypic SARS-CoV-2-RBD nanoparticles or COVID-19 convalescent human plasmas. Moreover, after priming, sera from mosaic RBD-immunized mice neutralized heterologous pseudotyped coronaviruses as well as or better than sera from homotypic SARS-CoV-2-RBD nanoparticle immunizations, demonstrating no loss of immunogenicity against particular RBDs resulting from co-display. A single immunization with mosaic RBD nanoparticles provides a potential strategy to simultaneously protect against SARS-CoV-2 and emerging zoonotic coronaviruses.

Original publication

DOI

10.1126/science.abf6840

Type

Journal article

Journal

Science

Publication Date

12/02/2021

Volume

371

Pages

735 - 741

Keywords

Animals, Antibodies, Neutralizing, Antibodies, Viral, Betacoronavirus, COVID-19, COVID-19 Vaccines, Coronavirus Infections, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Female, Immune Sera, Immunization, Immunoglobulin G, Mice, Mice, Inbred BALB C, Nanoparticles, Neutralization Tests, Protein Domains, Receptors, Antigen, B-Cell, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Viral Zoonoses